These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36829)
21. Effects of methylxanthines on the fetus. Soyka LF Clin Perinatol; 1979 Mar; 6(1):37-51. PubMed ID: 225087 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic and pharmacodynamic considerations for the design and screening of potential medications. DeVane CL NIDA Res Monogr; 1995; 149():116-29. PubMed ID: 8775838 [No Abstract] [Full Text] [Related]
27. Principles of Pharmacokinetics in the Pregnant Woman and Fetus. Ward RM; Varner MW Clin Perinatol; 2019 Jun; 46(2):383-398. PubMed ID: 31010566 [TBL] [Abstract][Full Text] [Related]
28. The transfer of drugs across the placenta. Long RF; Marks J Proc R Soc Med; 1969 Apr; 62(4):318-21. PubMed ID: 5811928 [No Abstract] [Full Text] [Related]
29. [Dosage and adverse effect problems in pregnancy]. Kuemmerle HP Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):356-9. PubMed ID: 5148893 [No Abstract] [Full Text] [Related]
30. Drugs and the fetomaternal unit. Brock-Utne JG; Downing JW; Mankowitz E S Afr Med J; 1980 Aug; 58(9):366-9. PubMed ID: 7404257 [TBL] [Abstract][Full Text] [Related]
31. [The clinical and pharmacological significance of drug binding by blood plasma proteins in the mother-placenta-fetus system]. Bender KI; Lutsevich NF; Lutsevich AN Vrach Delo; 1991 Nov; (11):35-41. PubMed ID: 1801429 [No Abstract] [Full Text] [Related]
32. [Horizons and frontiers of fetal pharmacology]. Salvati A Minerva Med; 1970 Jun; 61(46):2597-8. PubMed ID: 5425740 [No Abstract] [Full Text] [Related]
33. Alterations in drug disposition during pregnancy: implications for drug therapy. Hodge LS; Tracy TS Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):557-71. PubMed ID: 17696806 [TBL] [Abstract][Full Text] [Related]
34. [Clinical pharmacology for midwives. 2. Pregnancy and drugs. (2). Maternal-fetal exchange]. Yanaginuma T Josanpu Zasshi; 1984 May; 38(5):430-6. PubMed ID: 6564208 [No Abstract] [Full Text] [Related]
35. Metabolic capabilities of the human fetus: drug biotransformation. Juchau MR Addict Dis; 1975; 2(1-2):37-43. PubMed ID: 1163372 [No Abstract] [Full Text] [Related]
36. Maternal and fetal distribution of drugs in pregnancy. Mirkin BL Clin Pharmacol Ther; 1973; 14(4):643-7. PubMed ID: 4737092 [No Abstract] [Full Text] [Related]
38. Drug disposition and effects in the fetus. Rurak DW; Wright MR; Axelson JE J Dev Physiol; 1991 Jan; 15(1):33-44. PubMed ID: 1678754 [TBL] [Abstract][Full Text] [Related]
39. Placental drug transporters and their role in fetal protection. Iqbal M; Audette MC; Petropoulos S; Gibb W; Matthews SG Placenta; 2012 Mar; 33(3):137-42. PubMed ID: 22265855 [TBL] [Abstract][Full Text] [Related]
40. Diphenhydramine disposition in the sheep maternal-placental-fetal unit: gestational age, plasma drug protein binding, and umbilical blood flow effects on clearance. Kumar S; Tonn GR; Riggs KW; Rurak DW Drug Metab Dispos; 2000 Mar; 28(3):279-85. PubMed ID: 10681371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]